Enterprise List
The company is committed to building a biomedical health industry service provider that integrates research and development, production, and sales of medical biosynthetic technology, AI artificial intelligence protein analysis technology, protein modification technology, high-end microneedles, and long-acting microsphere precise delivery technology. The company develops high-end bio synthetic humanized collagen raw materials: Type I, III, I+III, XVII collagen, as well as application technology solutions for Type II, III implantable, adhesive, and puncture products. The product will be widely used in medical fields such as biomaterials, dermatology, medical beauty, bone transplant materials, and prosthesis transplantation.
The company owns the SmartEvolutionary Al algorithm platform with core intellectual property rights, which has developed three major biomanufacturing functional modules (industrial protein design and biocatalysis, cell factory construction and microbial manufacturing, green and efficient separation and bioprocessing integration). It has comprehensive capabilities for rapid research and development and efficient biomanufacturing, and can quickly complete molecular design, production process research and development, and large-scale industrial manufacturing of biological products including functional proteins, RNA molecules, and biobased raw materials. At present, Baikuirui has built nearly 3000 square meters of modern synthetic biology research and pilot bases in Shenzhen and Tianjin, with postdoctoral research workstations. It has been recognized as a "specialized and innovative enterprise", "high-tech enterprise", "seed unicorn enterprise", "synthetic biology enterprise" and other qualifications.
Angelo utilizes synthetic biology, innovative bioreactors, and plant cell factories to focus on the research, development, large-scale production, and application of SOD functional proteases, EcN gut microbiota colonization, NAMPT anti-aging protein factors, and natural pigments of glutathione. Having complete independent intellectual property rights, original plant and core technology, as well as an industrial system, we have achieved a matrix breakthrough and technological closed-loop from "bio intelligent lithography machines" to "bio intelligent chips" to "synthetic bio intelligent operating systems".
Senruis Biotechnology (Shenzhen) Co., Ltd. was established in 2019 and is an international high-tech company engaged in research and development as well as production in the field of synthetic biology.
Signor Biotech was founded by a research team from Tsinghua University, combining cutting-edge medical and engineering technologies to highly restore the physiological state of maternal tissues and form "micro organs" (i.e. organoids) composed of multiple cell types.
